Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.52 |
| ▸ | MME | P08473 | 4/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | CTRB1 | P17538 | 5/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.40 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.40 |
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17545410 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL380599 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL29898350 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL380600 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL9698824 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL574263 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL476353 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL159553 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| SCHEMBL159552 | 1.00 | DPP4 (0.52) | DPP4MMEACECPA1ACE2 | |
| Water SCHEMBL23711627 | 0.98 | DPP4 (0.50) | DPP4MMEACECPA1ACE2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5374551-A | Measurement of metabolism of alpha-methyl glucoside | BIOLOG, INC. (US) | 1994-12-20 | — | — | US | claimed |
| WO-2023250341-A2 | HUMAN CD33 ANTIBODIES AND GLUCOCORTICOID CONJUGATES | ELI LILLY AND COMPANY (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023235738-A1 | HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ELI LILLY AND COMPANY (US) | 2023-12-07 | — | — | WO | disclosed |
| WO-2023220549-A1 | HUMAN TUMOR NECROSIS FACTOR ALPHA ANTIBODY GLUCOCORTICOID CONJUGATES | ELI LILLY AND COMPANY (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-4247160-A1 | BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES | Agrospheres, Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| EP-4129324-A1 | COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST | Adocia (FR) | 2023-02-08 | — | — | EP | disclosed |
| CN-115700272-A | Supermolecule amino acid or salt thereof, and preparation and application thereof | 苏州欧丽特生物医药有限公司 | 2023-02-07 | — | — | CN | disclosed |
| WO-2022108944-A1 | BIOHERBICIDES FOR CONTROLLING ONE OR MORE PLANT SPECIES | AGROSPHERES, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| EP-3989999-A1 | NEW COMPOSITION CONTAINING BRANCHED-CHAIN AMINO ACIDS | Dompé farmaceutici SpA (IT) | 2022-05-04 | — | — | EP | disclosed |
| WO-2021074831-A1 | STABILIZED CONAZOLE COMPOSITION | UPL Corporation Limited (MU) | 2021-04-22 | — | — | WO | disclosed |
| US-5580872-A | ADMINISTERING IN THE TREATMENT OF BACTERIAL INFECTIONS | ABBOTT LABORATORIES (US) | 1996-12-03 | — | — | US | disclosed |
| EP-0729972-A1 | Peptide derivatives of tetrahydronaphthalene | F. HOFFMANN-LA ROCHE AG (CH) | 1996-09-04 | — | — | EP | disclosed |
| EP-0723545-A1 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LABORATORIES (US) | 1996-07-31 | — | — | EP | disclosed |
| WO-1995010519-A1 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LABORATORIES (US) | 1995-04-20 | — | — | WO | disclosed |
| EP-0527889-A4 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LAB (US) | 1994-08-10 | — | — | EP | disclosed |
| EP-0527889-A1 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LABORATORIES (US) | 1993-02-24 | — | — | EP | disclosed |
| EP-0490259-A2 | Aminoacid and peptid derivatives with renin inhibiting properties | MERCK PATENT GmbH (DE) | 1992-06-17 | — | — | EP | disclosed |
| EP-0474008-A1 | Amino acid derivatives | MERCK PATENT GmbH (DE) | 1992-03-11 | — | — | EP | disclosed |
| EP-0464517-A2 | Amino acid derivatives with renin inhibiting activity | MERCK PATENT GmbH (DE) | 1992-01-08 | — | — | EP | disclosed |
| WO-1991016894-A1 | QUINOLIZINONE TYPE COMPOUNDS | ABBOTT LABORATORIES (US) | 1991-11-14 | — | — | WO | disclosed |